Feiyang Biotechnology

Guangzhou Feiyang Biotechnology is a specialized biotechnology company focused on the development and manufacture of high-quality raw materials for the in vitro diagnostics (IVD) industry. Based in Guangzhou, China, the company provides a comprehensive portfolio of recombinant antigens and monoclonal antibodies used in diagnostic assays for infectious diseases, oncology, cardiology, and inflammation. Their products are designed for use in various platforms, including lateral flow assays, ELISA, and chemiluminescence immunoassay (CLIA). In addition to its catalog of diagnostic reagents, Feiyang Biotechnology offers contract services for protein expression and antibody engineering to support global diagnostic kit manufacturers. The company is ISO 13485 certified and serves as a critical supplier in the global diagnostic supply chain. During the COVID-19 pandemic, Feiyang Biotechnology became a key provider of SARS-CoV-2 antigens and antibodies for rapid testing kits worldwide.